Jay Hartenbach

Role: Chief Operating Officer at Diakonos Oncology
Location: Huntsville, AL, US
LinkedIn followers: 500 followers

OperationsView LinkedIn profile

Experience

Chief Operating Officer
Diakonos Oncology
Sep 2022 — Present

Education

Duke University
Master of Engineering Management
2012 — 2013
University of Miami
Bachelor of Science (B.S.)
2008 — 2012

Skills

Market Research
Powerpoint
Sales
Decision Modeling
Engineering
Microsoft Office
Cross-Functional Team Leadership
Management Consulting
Leadership
Crystal Ball
Data Analysis
Golf
Business Strategy
Microsoft Word
Business Analysis
Statistics
Vba
Program Management
Matlab
Project Management
Minitab
Six Sigma
Consulting
Team Leadership
Microsoft Excel
Management
Databases
Engineering Management
Ms Project
Microsoft Project
Analysis
Business Development

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
j••••••••@diakonosoncology.com
Personal email
•••••@•••••.com
Direct dial
+19•••••••15

Unlock verified contacts

Free to start · No credit card required

Current company

Diakonos Oncology

Pharmaceutical Manufacturing · 23 employees · Founded 2016 · Houston, Texas, United States

Diakonos Oncology is a clinical-stage immuno-oncology company advancing DOC1021, a first-in-class autologous dendritic cell immunotherapy designed for aggressive, treatment-resistant solid tumors. Unlike legacy dendritic cell approaches, DOC1021 is a tumor-informed, double-loaded platform that trains the immune system using a patient’s own tumor biology. By presenting both tumor lysate and tumor mRNA, the therapy is designed to activate a broader, more durable immune response against heterogeneous solid tumors. In glioblastoma, early clinical data demonstrated a 88% 12-month survival rate and a favorable safety profile. DOC1021 has received multiple FDA Fast Track designations and is currently being evaluated in clinical trials for glioblastoma, pancreatic cancer, and refractory melanoma at leading U.S. treatment centers. Diakonos has raised approximately $40M to date, including a $7.1M award from CPRIT supporting ongoing development. Our mission is to unlock the full potential of the immune system in cancers where durable options remain limited.

diakonosoncology.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Experience

Chief Operating Officer

Education

Duke University

University of Miami

Skills

Find verified contacts for anyone on LinkedIn